Biosimilar Reimbursement in the US Marketplace
Biosimilar Reimbursement in the US Marketplace
Keyword(s)
Biosimilars
Experts delve into the adaptation of the US biosimilars landscape to address uptake barriers in the US and explore the implications of recent reimbursement policies on biosimilar utilization. The impact of the changing China regulatory environment on the potential of biosimilars and opportunities for inclusion of that country as a target region for global development will be examined.
Register Here!
Description
Experts will delve into the adaptation of the US biosimilars landscape to address uptake barriers in the US and explore the implications of recent reimbursement policies on biosimilar utilization. The impact of the changing China regulatory environment on the potential of biosimilars and opportunities for inclusion of that country as a target region for global development will be examined.
Featured Topics Include:
- Biosimilar Reimbursement in the US Marketplace
- Payments for biosimilars under Medicare Part B: J-code, Pass-through, implications, key outstanding issues
- Payments for biosimilars under Medicare Part D: Coverage Gap, cost-sharing changes, implications and key outstanding issues
- Biosimilars to be Subject to Changes to 340B Drug Pricing
Courses in package:
No Records Found